• Citer

Demyelination as a complication of new immunomodulatory treatments.

par Lysandropoulos, Andreas ;Du Pasquier, Renaud A
Référence Current opinion in neurology, 23, 3, page (226-233)
Publication Publié, 2010-06

Article révisé par les pairs

• Détails
• Contenu

Titre:	Demyelination as a complication of new immunomodulatory treatments.
Auteur:	Lysandropoulos, Andreas; Du Pasquier, Renaud A
Informations sur la publication:	Current opinion in neurology, 23, 3, page (226-233)
Statut de publication:	Publié, 2010-06
Sujet CREF:	Neurologie
MeSH keywords:	Animals
	Antibodies, Monoclonal -- adverse effects
	Antibodies, Monoclonal, Humanized
	Antibodies, Monoclonal, Murine-Derived
	Demyelinating Diseases -- chemically induced -- drug therapy -- physiopathology
	Humans
	Iatrogenic Disease -- prevention & control
	Immunologic Factors -- adverse effects
	Leukoencephalopathy, Progressive Multifocal -- chemically induced -- immunology -- physiopathology
	Nervous System -- drug effects -- immunology -- physiopathology
	Risk Assessment -- standards
	Tumor Necrosis Factor-alpha -- antagonists & inhibitors -- immunology
Note générale:	Journal Article
	Research Support, Non-U.S. Gov't
	Review
Langue:	Anglais
Identificateurs:	urn:issn:1350-7540
	info:doi/10.1097/WCO.0b013e3283398c96
	info:pii/00019052-201006000-00006
	info:pmid/20442571